Genetic Technology Alert. Bacteriophage Aids in Effort to Destroy Enterococcus Faecalis Bacteria; Preventing Salmonellosis through the Usage of Lytic Bacteriophages; Development of Multiple Phage Therapy Products for Infectious Diseases

USD 250

* Required Fields

USD 250

PAY BY INVOICE

Be the first to review this product

This issue profiles a bacteriophage that aids efforts to destroy Enterococcus Faecalis bacteria, preventing salmonellosis through the usage of lytic bacteriophages, and development of multiple phage therapy products for infectious diseases .

Table of Contents

Genetic Technology Alert. Bacteriophage Aids in Effort to Destroy Enterococcus Faecalis Bacteria; Preventing Salmonellosis through the Usage of Lytic Bacteriophages; Development of Multiple Phage Therapy Products for Infectious DiseasesIn This Issue1. BACTERIOPHAGE AIDS IN EFFORT TO DESTROY ENTEROCOCCUS FAECALIS BACTERIA2. PREVENTING SALMONELLOSIS THROUGH THE USAGE OF LYTIC BACTERIOPHAGES3. DEVELOPMENT OF MULTIPLE PHAGE THERAPY PRODUCTS FOR INFECTIOUS DISEASES 4. RECENT PATENTS ON PHAGE THERAPY




Related Research

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.